Literature DB >> 1725147

The use of oral antibiotics in daily clinical practice.

A Verghese1.   

Abstract

In the treatment of infectious diseases in daily clinical practice, the physician is faced with a wide choice of antibiotics. Rational antibiotic use requires knowledge of the pathogens causing disease at that site, and the prevalence of resistance. In outpatient respiratory tract infection, for example, 3 pathogens, Branhamella (Moraxella) catarrhalis, Haemophilus influenzae and Streptococcus pneumoniae, predominate, beta-Lactamase production by the first 2 is a significant factor in antibiotic selection for respiratory tract infection. Empirical antibiotics are selected for efficacy, cost-effectiveness, safety and patient compliance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725147     DOI: 10.2165/00003495-199100424-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.

Authors:  A Verghese; D Roberson; J H Kalbfleisch; F Sarubbi
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

4.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

Authors:  P A Shurin; C D Marchant; C H Kim; G F Van Hare; C E Johnson; M A Tutihasi; L J Knapp
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

5.  Ampicillin, tetracycline, and chloramphenicol resistant Haemophilus influenzae in adults with chronic lung disease. Relationship of resistance to prior antimicrobial therapy.

Authors:  R J Wallace; L C Steele; D L Brooks; G D Forrester; J G Garcia; J I Luman; R W Wilson; S Shepherd; J Mclarty
Journal:  Am Rev Respir Dis       Date:  1988-03

6.  In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.

Authors:  H C Neu
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

7.  Outbreak of multiresistant non-encapsulated Haemophilus influenzae infections in a pulmonary rehabilitation centre.

Authors:  A W Sturm; R Mostert; P J Rouing; B van Klingeren; L van Alphen
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

  7 in total
  2 in total

1.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Cost-effectiveness opportunities for new antibiotics.

Authors:  A Hillman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.